Australia's pharmaceuticals watchdog is investigating a spike in adverse event reports for Vyvanse, the country's most commonly prescribed ADHD medication. The increase coincides with a leap in ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Less than four months after Teva’s Adderall was erased from the FDA shortage list, supply problems with another attention-deficit/hyperactivity disorder (ADHD ...

In a significant move to mitigate the ongoing shortage of ADHD medications in the U.S., the Drug Enforcement Administration (DEA) has authorized a substantial increase in the production limits for ...

WASHINGTON — The Drug Enforcement Administration has increased the production limit for the ADHD drug Vyvanse and its generic versions to combat the medicine's ongoing shortage, according to a notice ...

The Drug Enforcement Administration is allowing increased production of the ADHD medication Vyvanse and its generic form, lisdexamfetamine. Underproduction of the ADHD medication Adderall along with ...

The Drug Enforcement Administration has increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in ...

In my practice, I’ve found that most adults with ADHD struggled as far back as elementary school. Their parents yelled at them about their poor grades and not doing their homework, but they didn’t ...

Women with attention-deficit/hyperactivity disorder (ADHD) face delayed diagnosis and worse outcomes than men, according to a ...